Affimed NV logo

Affimed NV

2
NAS:AFMD (Germany)  
$ 6.21 -0.527 (-7.82%) 02:43 PM EST
At Loss
P/B:
2.14
Market Cap:
$ 94.61M
Enterprise V:
$ 67.22M
Volume:
149.41K
Avg Vol (2M):
970.57K
Trade In:
Volume:
149.41K
At Loss
Avg Vol (2M):
970.57K

Business Description

Description
Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.
Name Current Vs Industry Vs History
Cash-To-Debt 3.07
Equity-to-Asset 0.58
Debt-to-Equity 0.4
Debt-to-EBITDA -0.18
Altman Z-Score -12.51
Distress
Grey
Safe
Beneish M-Score 8.76
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 58.09
9-Day RSI 61.93
14-Day RSI 61.22
6-1 Month Momentum % 35.8
12-1 Month Momentum % -27.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.06
Quick Ratio 3.06
Cash Ratio 2.43
Days Sales Outstanding 337.52

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.1
Shareholder Yield % -1.74

Financials (Next Earnings Date:2024-08-09 Est.)

AFMD's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AFMD

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Affimed NV Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 4.218
EPS (TTM) ($) -6.771
Beta 1.28
Volatility % 63.97
14-Day RSI 61.22
14-Day ATR ($) 0.73933
20-Day SMA ($) 5.652
12-1 Month Momentum % -27.29
52-Week Range ($) 2.235 - 8.95
Shares Outstanding (Mil) 15.23

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Affimed NV Filings

Filing Date Document Date Form
No Filing Data

Affimed NV Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Affimed NV Frequently Asked Questions

What is Affimed NV(AFMD)'s stock price today?
The current price of AFMD is $6.21. The 52 week high of AFMD is $8.95 and 52 week low is $2.24.
When is next earnings date of Affimed NV(AFMD)?
The next earnings date of Affimed NV(AFMD) is 2024-08-09 Est..
Does Affimed NV(AFMD) pay dividends? If so, how much?
Affimed NV(AFMD) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1